6808 logo

3D Global Biotech TPEX:6808 Stock Report

Last Price

NT$64.10

Market Cap

NT$5.0b

7D

7.7%

1Y

121.0%

Updated

06 Feb, 2025

Data

Company Financials

My Notes

Capture your thoughts, links and company narrative

3D Global Biotech Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for 3D Global Biotech
Historical stock prices
Current Share PriceNT$64.10
52 Week HighNT$73.50
52 Week LowNT$25.75
Beta0.39
1 Month Change-1.38%
3 Month Change66.06%
1 Year Change121.03%
3 Year Change80.06%
5 Year Changen/a
Change since IPO26.43%

Recent News & Updates

Recent updates

Shareholder Returns

6808TW BiotechsTW Market
7D7.7%1.1%-1.4%
1Y121.0%14.3%25.5%

Return vs Industry: 6808 exceeded the TW Biotechs industry which returned 14.3% over the past year.

Return vs Market: 6808 exceeded the TW Market which returned 25.5% over the past year.

Price Volatility

Is 6808's price volatile compared to industry and market?
6808 volatility
6808 Average Weekly Movement7.3%
Biotechs Industry Average Movement5.1%
Market Average Movement4.5%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 6808's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 6808's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
201433Keng-Liang Ouwww.3dglobalbiotech.com.tw

3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research.

3D Global Biotech Inc. Fundamentals Summary

How do 3D Global Biotech's earnings and revenue compare to its market cap?
6808 fundamental statistics
Market capNT$4.95b
Earnings (TTM)-NT$29.41m
Revenue (TTM)NT$55.15m

90.5x

P/S Ratio

-169.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6808 income statement (TTM)
RevenueNT$55.15m
Cost of RevenueNT$19.79m
Gross ProfitNT$35.36m
Other ExpensesNT$64.77m
Earnings-NT$29.41m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.38
Gross Margin64.12%
Net Profit Margin-53.32%
Debt/Equity Ratio0%

How did 6808 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 11:59
End of Day Share Price 2025/02/06 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

3D Global Biotech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.